
    
      The overall objective of the study is to determine if antibiotic therapy is beneficial in
      children with pneumonia who do not have a highly suspicious bacterial infection, such as in
      lobar pneumonia.

      Secondary objective is to determine whether antibiotic use influence the microbial flora,
      including antibiotic resistance, in the airways in the short or medium long term.

      The study is a phase IV double-blind, placebo-controlled, multicenter, nationwide, randomized
      superiority trial of amoxicillin versus placebo in children aged 1-5 years of age with a
      lower respiratory infection.
    
  